Fred B. Craves, Director at PONIARD PHARMACEUTICALS, INC. (PARD), bought 12,900 shares at $1.87 ($25K) on 2008-12-17, disclosed to the SEC on 2008-12-17.
Open-market purchase of $25k PARD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.84 | 600 | $1K | 4.5% |
| 2 | $1.85 | 200 | $370 | 1.5% |
| 3 | $1.86 | 1,200 | $2K | 9.1% |
| 4 | $1.87 | 500 | $935 | 3.8% |
| 5 | $1.88 | 600 | $1K | 4.6% |
| 6 | $1.89 | 915 |
| $2K |
| 7.0% |
| 7 | $1.90 | 3,385 | $6K | 26.1% |
| 8 | $1.91 | 100 | $191 | 0.8% |
| 9 | $1.91 | 1,000 | $2K | 7.7% |
| 10 | $1.92 | 100 | $192 | 0.8% |
| 11 | $1.92 | 900 | $2K | 7.0% |
| 12 | $1.92 | 200 | $384 | 1.6% |
| 13 | $1.93 | 100 | $193 | 0.8% |
| 14 | $1.94 | 200 | $388 | 1.6% |
| 15 | $1.95 | 200 | $390 | 1.6% |
| 16 | $1.96 | 700 | $1K | 5.6% |
| 17 | $1.97 | 300 | $591 | 2.4% |
| 18 | $1.99 | 800 | $2K | 6.5% |
| 19 | $1.99 | 100 | $199 | 0.8% |
| 20 | $2.00 | 600 | $1K | 4.9% |
| 21 | $2.01 | 200 | $402 | 1.6% |
| Total | $1.91 avg | 12,900 | $25K | 100% |
| Filing → |
| MDGL | SELL | 2024-11-27 | $1.2M | — | Filing → |
| MDGL | SELL | 2024-05-16 | $9.3M | — | Filing → |
| MDGL | SELL | 2020-08-19 | $5.2M | — | Filing → |